Wyatt Gotbetter

Global Head of Evidence, Value and Access

Wyatt Gotbetter brings over 25 years of experience in life sciences, strategy consulting, and commercial leadership to Cytel. He is currently Global Head Evidence, Value and Access (EVA) at Cytel, where he leads teams in supporting clients to bring novel products to market to address unmet patient needs. He is a passionate advocate for the use of data-driven strategies to demonstrate value and foster innovation in life sciences.

Before joining Cytel, Wyatt served as Senior Vice President and Worldwide Head of Parexel Access Consulting. Prior to that, he held leadership roles across consulting and industry, including Partner at Health Advances, Manager at Boston Consulting Group (BCG), and Principal at Decision Resources Group (DRG), and in industry as the Head of New Product Commercialization for Biogen, and Director of US Payer Relations for Boston Scientific.

Wyatt is currently a board member of Diceros Therapeutics, faculty/executive in residence at Cornell University, Value and Access Editor for the Drug Information Association Global Forum, and a faculty member for BIO’s annual Business Development Fundamentals course.

He holds a Bachelor of Science and a Master of Public Administration (M.P.A.) degree from Cornell University, with a focus on health economics and policy.